Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Molecular neurobiology - 1 Jun 2021

Cho Sukhee, Lee Hyein, Seo Jinsoo

Abstract excerpt

Alzheimer's disease (AD) is a devastating neurodegenerative disease that affects more than 30 million people worldwide. Despite growing knowledge of AD pathophysiology, a complete understanding of the pathogenic mechanisms underpinning AD is lacking, and there is currently no cure for AD. Extant literature suggests that AD is a polygenic and multifactorial disease underscored by complex and dynamic pathogenic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Glycolysis

Share to Risk Factors

Source

Identifiers

PMID: 33479841
DOI: 10.1007/s12035-021-02297-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.PMID 33479841Read ↗

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive ReviewSemantic proximity Read ↗

Genetics of Alzheimer’s diseaseSemantic proximity Read ↗

Genetic and physiological basis of Alzheimer’s disease: A reviewSemantic proximity Read ↗

Deciphering the genetic basis of Alzheimer's disease.Semantic proximity Read ↗

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Semantic proximity Read ↗

Pharmacogenomics in Alzheimer's disease.Semantic proximity Read ↗

Insulin resistance in Alzheimer’s disease: The genetics and metabolomics linksSemantic proximity Read ↗

A global view of the genetic basis of Alzheimer disease.Semantic proximity Read ↗

Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation StrategiesSemantic proximity Read ↗

Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and NeuroinflammationSemantic proximity Read ↗

The multifaceted roles of apolipoprotein E4 in Alzheimer’s disease pathology and potential therapeutic strategiesSemantic proximity Read ↗

Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.